Early coronary angiography in NSTEMI: a regional Victorian perspective.

IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Internal Medicine Journal Pub Date : 2024-10-01 Epub Date: 2024-07-03 DOI:10.1111/imj.16465
Anand Ganes, James Henderson, Rohit Samuel, Louise Segan, Chin Hiew, Adam Hutchison
{"title":"Early coronary angiography in NSTEMI: a regional Victorian perspective.","authors":"Anand Ganes, James Henderson, Rohit Samuel, Louise Segan, Chin Hiew, Adam Hutchison","doi":"10.1111/imj.16465","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Current guidelines highlight a paucity of evidence guiding optimal timing for non-ST-elevation myocardial infarction (NSTEMI) in high-risk and non-high-risk cases.</p><p><strong>Aim: </strong>We assessed long-term major adverse cardiovascular events (MACEs) in NSTEMI patients undergoing early (<24 h) versus delayed (>24 h) coronary angiography at 6 years. Secondary end-points included all-cause mortality and cumulative MACE outcomes.</p><p><strong>Methods: </strong>Baseline characteristics and clinical outcomes were assessed among 355 patients presenting to a tertiary regional hospital between 2017 and 2018. Cox proportional hazard models were generated for MACE and all-cause mortality outcomes, adjusting for the Global Registry of Acute Coronary Events (GRACE) score, patient demographics, biomarkers and comorbidities.</p><p><strong>Results: </strong>Two hundred and seventy patients were included; 147 (54.4%) and 123 (45.6%) underwent early and delayed coronary angiography respectively. Median time to coronary angiography was 13.3 and 45.4 h respectively. At 6 years, 103 patients (38.1%) experienced MACE; 41 in the early group and 62 in the delayed group (hazard ratio (HR) = 2.23; 95% confidence interval (CI) = 1.50-3.31). After multivariable adjustment, the delayed group had higher rates of MACE (HR = 1.79; 95% CI = 1.19-2.70), all-cause mortality (HR = 2.76; 95% CI = 1.36-5.63) and cumulative MACE (incidence rate ratio = 1.54; 95% CI = 1.12-2.11). Subgroup analysis of MACE outcomes in rural and weekend NSTEMI presentations was not significant between early and delayed coronary angiography (HR = 1.49; 95% CI = 0.83-2.62).</p><p><strong>Conclusion: </strong>Higher MACE rates in the delayed intervention group suggest further investigation is needed. Randomised control trials would be well suited to assess the role of early invasive intervention across all NSTEMI risk groups.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/imj.16465","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Current guidelines highlight a paucity of evidence guiding optimal timing for non-ST-elevation myocardial infarction (NSTEMI) in high-risk and non-high-risk cases.

Aim: We assessed long-term major adverse cardiovascular events (MACEs) in NSTEMI patients undergoing early (<24 h) versus delayed (>24 h) coronary angiography at 6 years. Secondary end-points included all-cause mortality and cumulative MACE outcomes.

Methods: Baseline characteristics and clinical outcomes were assessed among 355 patients presenting to a tertiary regional hospital between 2017 and 2018. Cox proportional hazard models were generated for MACE and all-cause mortality outcomes, adjusting for the Global Registry of Acute Coronary Events (GRACE) score, patient demographics, biomarkers and comorbidities.

Results: Two hundred and seventy patients were included; 147 (54.4%) and 123 (45.6%) underwent early and delayed coronary angiography respectively. Median time to coronary angiography was 13.3 and 45.4 h respectively. At 6 years, 103 patients (38.1%) experienced MACE; 41 in the early group and 62 in the delayed group (hazard ratio (HR) = 2.23; 95% confidence interval (CI) = 1.50-3.31). After multivariable adjustment, the delayed group had higher rates of MACE (HR = 1.79; 95% CI = 1.19-2.70), all-cause mortality (HR = 2.76; 95% CI = 1.36-5.63) and cumulative MACE (incidence rate ratio = 1.54; 95% CI = 1.12-2.11). Subgroup analysis of MACE outcomes in rural and weekend NSTEMI presentations was not significant between early and delayed coronary angiography (HR = 1.49; 95% CI = 0.83-2.62).

Conclusion: Higher MACE rates in the delayed intervention group suggest further investigation is needed. Randomised control trials would be well suited to assess the role of early invasive intervention across all NSTEMI risk groups.

NSTEMI 早期冠状动脉造影:维多利亚地区的观点。
背景:目的:我们评估了接受早期(24 小时)冠状动脉造影术的 NSTEMI 患者在 6 年后的长期主要不良心血管事件(MACE)。次要终点包括全因死亡率和累积MACE结果:对2017年至2018年期间在一家三级地区医院就诊的355名患者的基线特征和临床结局进行了评估。根据急性冠状动脉事件全球登记(GRACE)评分、患者人口统计学特征、生物标志物和合并症进行调整后,针对MACE和全因死亡率结果生成了Cox比例危险模型:共纳入 270 名患者,其中分别有 147 人(54.4%)和 123 人(45.6%)接受了早期和延迟冠状动脉造影术。冠状动脉造影的中位时间分别为 13.3 小时和 45.4 小时。6年后,103名患者(38.1%)发生MACE,其中早期组41人,延迟组62人(危险比(HR)=2.23;95%置信区间(CI)=1.50-3.31)。经多变量调整后,延迟组的 MACE(危险比 = 1.79;95% 置信区间 = 1.19-2.70)、全因死亡率(危险比 = 2.76;95% 置信区间 = 1.36-5.63)和累积 MACE(发病率比 = 1.54;95% 置信区间 = 1.12-2.11)发生率更高。对农村和周末NSTEMI患者的MACE结果进行亚组分析,发现早期和延迟冠状动脉造影术的MACE结果差异不大(HR = 1.49; 95% CI = 0.83-2.62):结论:延迟干预组的MACE发生率较高,表明需要进一步研究。随机对照试验非常适合评估早期介入治疗在所有NSTEMI风险组中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Internal Medicine Journal
Internal Medicine Journal 医学-医学:内科
CiteScore
3.50
自引率
4.80%
发文量
600
审稿时长
3-6 weeks
期刊介绍: The Internal Medicine Journal is the official journal of the Adult Medicine Division of The Royal Australasian College of Physicians (RACP). Its purpose is to publish high-quality internationally competitive peer-reviewed original medical research, both laboratory and clinical, relating to the study and research of human disease. Papers will be considered from all areas of medical practice and science. The Journal also has a major role in continuing medical education and publishes review articles relevant to physician education.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信